rs200088180

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_003482.4(KMT2D):​c.1940C>T​(p.Pro647Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000883 in 1,585,460 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P647T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 28)
Exomes 𝑓: 0.0000084 ( 0 hom. )

Consequence

KMT2D
NM_003482.4 missense

Scores

1
2
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.50

Publications

9 publications found
Variant links:
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
KMT2D Gene-Disease associations (from GenCC):
  • choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
  • Kabuki syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12488508).
BS2
High AC in GnomAdExome4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2DNM_003482.4 linkc.1940C>T p.Pro647Leu missense_variant Exon 11 of 55 ENST00000301067.12 NP_003473.3 O14686-1Q59FG6Q6PIA1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2DENST00000301067.12 linkc.1940C>T p.Pro647Leu missense_variant Exon 11 of 55 5 NM_003482.4 ENSP00000301067.7 O14686-1
KMT2DENST00000683543.2 linkc.1940C>T p.Pro647Leu missense_variant Exon 11 of 56 ENSP00000506726.1 A0A804HHR9
KMT2DENST00000685166.1 linkc.1940C>T p.Pro647Leu missense_variant Exon 10 of 54 ENSP00000509386.1 O14686-3
KMT2DENST00000692637.1 linkc.1940C>T p.Pro647Leu missense_variant Exon 10 of 54 ENSP00000509666.1 A0A8I5KSG1

Frequencies

GnomAD3 genomes
AF:
0.0000134
AC:
2
AN:
149316
Hom.:
0
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.0000496
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000836
AC:
12
AN:
1436144
Hom.:
0
Cov.:
35
AF XY:
0.00000700
AC XY:
5
AN XY:
714306
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33048
American (AMR)
AF:
0.00
AC:
0
AN:
44494
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25690
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39330
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85578
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52942
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5716
European-Non Finnish (NFE)
AF:
0.0000110
AC:
12
AN:
1089972
Other (OTH)
AF:
0.00
AC:
0
AN:
59374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.617
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000134
AC:
2
AN:
149316
Hom.:
0
Cov.:
28
AF XY:
0.0000274
AC XY:
2
AN XY:
72884
show subpopulations
African (AFR)
AF:
0.0000496
AC:
2
AN:
40328
American (AMR)
AF:
0.00
AC:
0
AN:
15040
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3436
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5030
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4700
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10392
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
300
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67136
Other (OTH)
AF:
0.00
AC:
0
AN:
2054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Kabuki syndrome 1 Uncertain:1
-
Neuberg Centre For Genomic Medicine, NCGM
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The observed missense c.1940C>T(p.Pro647Leu) variant in KMT2D gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is absent in gnomAD Exomes. The amino acid Pro at position 647 is changed to a Leu changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Pro647Leu in KMT2D is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The variant is predicted as damaging by SIFT. For these reasons, this variant has been classified as Uncertain Significance. -

Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome;CN030661:Kabuki syndrome 1 Uncertain:1
Feb 21, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.0055
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
19
DANN
Benign
0.74
DEOGEN2
Benign
0.055
T
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.76
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.72
T
M_CAP
Pathogenic
0.37
D
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.5
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.20
Sift
Uncertain
0.0030
D
Polyphen
0.0050
B
Vest4
0.34
MutPred
0.25
Loss of glycosylation at P647 (P = 0.0135);
MVP
0.29
MPC
0.19
ClinPred
0.13
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.2
Varity_R
0.055
gMVP
0.28
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200088180; hg19: chr12-49445526; COSMIC: COSV56413885; API